Ratings by Barclays (Stephanie Davis)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/18/2026 | Waystar Holding | WAY | Maintain | Overweight (Overweight) |
|
Details | ||
| 1/30/2026 | Quest Diagnostics | DGX | Upgrade | Overweight (Equalweight) |
182.35 (199.21) |
9.25% | Details | |
| 12/9/2025 | Waystar Holding | WAY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/22/2025 | Quest Diagnostics | DGX | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/3/2025 | Quest Diagnostics | DGX | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/19/2025 | Waystar Holding | WAY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/31/2025 | Quest Diagnostics | DGX | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/14/2024 | OptimizeRX | OPRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/11/2024 | TruBridge Inc | TBRG | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/11/2024 | Lifestance Health Group | LFST | Maintain | Underweight (N/A) |
|
Details | ||
| 11/11/2024 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2024 | Evolent Health | EVH | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2024 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2024 | Waystar Holding | WAY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2024 | Omnicell | OMCL | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/29/2024 | TalkSpace | TALK | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/23/2024 | Quest Diagnostics | DGX | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/15/2024 | Doximity Inc | DOCS | Upgrade | Overweight (Equalweight) |
41.96 (25.34) |
-39.61% | Details | |
| 10/8/2024 | WW International lnc | WW | Maintain | Underweight (N/A) |
|
Details | ||
| 10/8/2024 | Accolade Inc. | ACCD | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/3/2024 | Evolent Health | EVH | Maintain | Overweight (N/A) |
|
Details | ||
| 9/26/2024 | Evolent Health | EVH | Maintain | Overweight (N/A) |
|
Details | ||
| 8/27/2024 | Quest Diagnostics | DGX | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/12/2024 | OptimizeRX | OPRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/9/2024 | Waystar Holding | WAY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2024 | Lifestance Health Group | LFST | Maintain | Underweight (N/A) |
|
Details | ||
| 8/9/2024 | Doximity Inc | DOCS | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/7/2024 | TalkSpace | TALK | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/2/2024 | WW International lnc | WW | Maintain | Underweight (N/A) |
|
Details | ||
| 8/2/2024 | Omnicell | OMCL | Upgrade | Equalweight (Underweight) |
29.21 (41.30) |
41.39% | Details | |
| 6/28/2024 | Accolade Inc. | ACCD | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/21/2024 | TalkSpace | TALK | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/20/2024 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/17/2024 | Doximity Inc | DOCS | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/16/2024 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/25/2024 | Quest Diagnostics | DGX | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/1/2024 | Weight Watchers International | WW | Maintain | Underweight (N/A) |
|
Details | ||
| 2/9/2024 | Omnicell | OMCL | Maintain | Underweight (N/A) |
|
Details | ||
| 2/2/2024 | Quest Diagnostics | DGX | Maintain | Equalweight (N/A) |
|
Details | ||
| 1/22/2024 | Computer Programs and Systems | CPSI | Maintain | Equalweight (N/A) |
|
Details |
